Abstract Interferon-gamma (IFN-γ) is considered a key cytokine involved in the preventive and defensive responses of T cells against infectious pathogens and tumors. Therefore, the transgenic expression of IFN-γ in specific T cells appears to be an obvious therapeutic possibility. To directly examine whether IFN-γ production can be increased in T cells, we introduced an IFN-γ encoding cDNA into IFN-γ −/− and IFN-γ +/+ CD8 + effector populations by retroviral transduction. Here, we show that CD8 T cells can be equipped with IFN-γ that increases their capacity to secrete the cytokine. Despite constitutive retroviral IFN-γ mRNA transcription, translation and secretion of IFN-γ protein was tightly regulated and only observed in activated T cells. Neither proliferation nor cytolytic activity of CTL was affected by IFN-γ transduction. Importantly, CD8 + T cells retrovirally transduced with IFN-γ exhibit augmented tumor suppressive capacity upon adoptive transfer into IFN-γ −/− mice. Thus, T cells can be readily armed with IFN-γ without risking immunopathology by dysregulated production of this highly potent proinflammatory cytokine.
in the fraction of IFN-γ producing CD8 + T lymphocytes [7, 8] . In addition, IFN-γ deficient mice and IFN-γ receptor deficient mice show impaired T-cell dependent immunity against certain infections [3] and tumors [9, 10] . In the absence of IFN-γ, T cells are not able to clear viral infection [11] and fail to enter the tumor tissue [9] . These and other data imply that IFN-γ secretion is a critical effector mechanism of CD8 + T cells in vivo. Hence, transgenic expression of IFN-γ in specific T cells appears to be an obvious therapeutic possibility.
Here, we show that CD8 + T cells can be readily equipped with IFN-γ by retroviral infection, increasing their IFN-γ secreting capacity and augmenting their therapeutic function.
Materials and methods

Mice
Inbred BALB/c mice were obtained from Harlan Olac (Bicester, UK), and BALB/c IFN-γ knockout mice were bred and maintained under standard housing conditions in the animal facility of the HZI.
The Clone-4 (CL4) TcR transgenic mouse line expresses an H-2K d restricted TcR (Vα10, Vβ8.2) against a transmembrane epitope of hemagglutinin (HA) from influenza virus comprising amino acids 512-520 (IYSTVASSL) of the strain A/PR/8/34 [12] . The transgenic line has been backcrossed over more than 12 generations onto the BALB/c background and was bred in the HZI animal facility. All mice used in the experiments were sex-and age-matched.
T cell activation and phenotype differentiation
Splenocytes from CL4TcR-transgenic mice were activated by influenza virus hemagglutinin peptide 512-520 (0,3 μg/ml) at 3×10 6 cells/ml in Iscove's modified Dulbecco's medium. Splenocytes from IFN-γ knockout mice were activated with plate-bound anti-TcR mAb (2C11) and anti-CD28 (37.51; 1 and 4 μg/ml respectively, both from Pharmingen) for 48 h. Cells were collected, washed, and transferred into medium containing 10 U/ml rhIL-2 at a cell density of 2×10 5 cells/ml. To obtain Tc1 and Tc2 cells, T cell cultures were supplemented with IL-12 (10 ng/ml) and anti-IL-4 mAb (10 μg/ml), or IL-4 (20 ng/ml), anti-IL-12 (10 μg/ml), and anti-IFN-γ (10 μg/ml) mAb, respectively (cytokines, R&D; antibodies, Pharmingen).
T cells from CL4TcR-transgenic mice were harvested on day 8 after primary activation and purified by cell sorting. At this time point, more than 98% of the CD8 + T cells expressed the transgenic T cell receptor as determined by staining with H-2K d /HA 512-520 tetramers (a kind gift from Dr. D. Bush, LMU, Munich, Germany). For passaging T cells, sorted cells from cultures were stimulated with HA peptide (0,3 μg/ml) at 1,25×10 5 cells/ml with irradiated BALB/c splenocytes (2,000 rad) as stimulators. Alternatively, sorted cells were expanded by polyclonal activation using anti-CD3-mAb (2C11) and anti-CD28 (37.51) coated plates. Polyclonally activated cells were collected after 24 h, washed and expanded in fresh medium containing 1 ng/ml rhIL-2 and 5 ng/ml rmIL-15. For analysis of IL-12/ IL-18-induced IFN-γ production, sorted populations were incubated at a density of 2×10 5 cells/well in a 96-well plate with 10 U/ml rmIL-12 and 10 ng/ml rmIL-18 (both R&D).
Retroviral construct and retroviral transduction
The IFN-γ coding sequence was amplified by reverse transcription polymerase chain reaction (RT-PCR) from the transfectant X63/BCMG NEO IFNγ (kindly provided by Dr. Karasuyama, Tokyo, Japan), using the forward primer G C G C G C A C TA G T G C C A C C AT G A A C G C TA C A CACTGC and the reverse primer ATAAGAGCGGCCGCT CAGCAGCGACTCCTTTTCCGC, and cloned into the pBluescript via SpeI/NotI resulting in the plasmid pBS-IFNγ. The IFN-γ coding fragment was excised from pBS-IFNγ using BamHI and NotI. This fragment was cloned into a XhoI-digested, blunt-ended, and subsequently BglIIdigested GFP-RV retroviral vector containing an internal ribosomal entry site (IRES) element for bi-cistronic expression (a kind gift from Dr. Kenneth Murphy, Howard Hughes Medical Institute, MD, USA) resulting in IFN/ GFP-RV. Thus, the final vector contains the coding sequence for IFN-γ without untranslated regions of the gene, followed by an IRES and the GFP coding sequence. Integrity and function were confirmed by enzymatic digestion of the vector and analyzing supernatants from plasmid-transfected 3T3 fibroblasts by IFN-γ ELISA. Phoenix-Eco packaging cells (Nolan/Stanford CA, purchased through ATCC) were transfected according to Dr. Nolan's protocol. Primary T cells were activated as described above and infected after 48 h using 1 vol of viral supernatant and polybrene (6 μg/ml, Sigma), centrifuged at 1,800 rpm for 45 min at room temperature, and incubated at 37°C for 48 h, before being supplied with fresh media and expanded until day 8 after primary activation.
RT-PCR
Transcription of the retroviral DNA was analyzed using RT-PCR. Retrovirally infected, CD8 + /GFP + -sorted CL4 TcR Tc1 cells were either stimulated for 24 h with plate-bound anti-CD3 antibodies or left unstimulated. RNA extraction and reverse transcription was carried out using standard procedures. Primers used for PCR were: GAPDH, ATCTTCTTGTGCAGTGCCAGG (forward) and ACTC CACGACATACTCAGCACC (reverse); total IFN-γ, AGTGGCATAGATGTGGAAGAAAAGAGTCTCTTCTTG (forward) and GGCGCTGGACCTGTGGGTTG (reverse); retroviral IFN-γ, CGTCATTGAATCACACCTG (forward) and GAACTTCAGGGTCAGCTT (reverse, binding to GFP); endogenous IFN-γ, AGTTCTGGGCTTCTCCTCCT (forward) and GTCACCATCCTTTTGCCAGT (reverse).
Intracellular IFN-γ staining
For intracellular staining of IFN-γ, cells were fixed for 20 min at room temperature in phosphate-buffered saline (PBS) 1% paraformaldehyde, followed by incubation in 0.1% NP40 in PBS for 3 min on ice. After washing, cells were incubated with PE-conjugated anti-IFN-γ mAb or the appropriate PE-conjugated isotype control (both Pharmingen) for 30 min on ice. Cells were analyzed by flow cytometry using a FACSCalibur (Becton Dickinson).
Cytotoxicity assay
The cytotoxic activity of CL4TcR CTL was determined using the JAM assay [13] . Briefly, 5,000 [ 3 H]-thymidinelabeled P815 were incubated in 96-well U-bottom plates with or without 1 μg/ml HA peptide 512-520 for 1 h. CL4TcR effector T cells were added at different ratios and the plates were incubated for a further 4 h. Percent cytotoxicity was calculated from the mean of triplicate wells.
HA tumors and tumor cell injections
Full-length HA cDNA from the Mt. Sinai strain of the PR8 influenza virus was subcloned into the pCDNA3 expression vector. The BALB/c colon carcinoma CT26 was transfected with this vector using standard methodology. CT26-HA were selected and grown in complete medium supplemented with G418 (500 μg/ml). The level of HA expression on transfected cells was determined by flow cytometry analysis, using the fluorescein isothiocyanate-conjugated HA-specific monoclonal antibody H36-4-5 [14] .
BALB/c IFN-γ knockout mice, 8-10 weeks of age, were inoculated s.c. with 1×10 5 CT26-HA transfectants with high HA expression and monitored for tumor growth every day. Tumor size was measured in two dimensions and given as the mean diameter. Explants of CT26-HA, obtained after 20 days of tumor progression, demonstrated that expression of HA was maintained in vivo as determined by staining with the antibody H36-4-5 against HA (data not shown).
Results
CD8
+ T cells can be retrovirally equipped with IFN-γ
To test whether IFN-γ production can be increased in T cells by ectopic expression of the IFN-γ gene, we retrovirally introduced an IFN-γ encoding cDNA into CD8 + T cells. A bi-cistronic retroviral vector was used to co-express murine IFN-γ together with GFP under the control of the murine stem cell virus long-terminal repeat (MSCV LTR; IFN/GFP-RV; Fig. 1a ). GFP-RV (Fig. 1a) served as negative control for these experiments. Using GFP as a reporter gene, transduced CD8 + T cells from transgenic CL4 mice were routinely enriched by cell sorting to purities greater than 95% (Fig. 1b,c) . + T cells were purified by FACSorting. c GFP-and CD8-positive T cells that were sorted from the populations described in b. Data are given as dot blot of live-gated events First, we determined whether IFN-γ can be expressed in CD8 + T cells via retroviral transduction. Therefore, we infected CD8 + T cells from IFN-γ knockout mice after anti-CD3 stimulation. Sorted GFP + CD8 + T cells infected with IFN/GFP-RV (Fig. 2a) , but not CD8 + T cells infected by control vector, secreted IFN-γ after restimulation with anti-CD3. When comparing transduction efficiency under Tc1 or Tc2 culture conditions, IFN-γ secretion was found to occur under both priming conditions, although TcR-activated Tc2 cells secreted less recombinant IFN-γ per cell than Tc1 cells did (Fig. 2a) . Interestingly, no IFN-γ production could be observed in resting T cells (Fig. 2a) , although the IFN-γ encoding cDNA was under the control of the viral LTR and the IFN/GFP-RV retrovirus did not contain any upstream regulatory elements of the IFN-γ gene [15, 16] . Pertinent to this observation, fibroblasts constitutively secreted the cytokine upon infection with IFN/GFP-RV virus (Fig. 2b) .
When IFN-γ competent CD8 + T cells were transduced with IFN/GFP-RV, an increase in TcR-induced IFN-γ secretion was observed compared to the levels produced by GFP-RV infected control CD8 + T cells (Fig. 2c) or GFP − cells from IFN/GFP-RV-infected cultures (not shown). Similar data were obtained when IFN/GFP-RV infected CD8 + T cells were stimulated with stimulator cells and peptide instead of anti-CD3 (Fig. 2d) . Together these data demonstrate that IFN-γ can be enhanced in CD8 + T cells by retroviral transduction. However, despite retroviral LTR control of the cDNA, IFN-γ secretion depends on activation of the T cells. + T cells were purified by cell sorting on day 8 (as in Fig. 1 ) and restimulated at a density of 1× 10 5 cells/well in a 96-well plate using 1 μg/ml plate bound anti-CD3 mAb. IFN-γ production was measured by ELISA from supernatants taken after 24 h of activation. d Same cells as under c were restimulated with irradiated feeder cells and 1 μg/ml peptide. Data are representative for at least three independent experiments. Note that the scales are different in the three panels It was unexpected that the secretion of retrovirally derived IFN-γ driven by the viral LTR was dependent on activation of the transduced T cells. This regulation could be either on a transcriptional or translational level. Since only the IFN-γ coding sequence was introduced into the vector and the reporter protein GFP (co-encoded by bi-cistronic mRNA) was found to be expressed, it was unlikely that regulation was on the transcriptional level. This was confirmed by RT-PCR on resting transduced T cells. Using primers that distinguished the virally derived IFN-γ specific mRNA from the endogenous transcript, we could show that significant amounts of IFN-γ encoding mRNA were present in resting T cells transduced with IFN/GFP-RV (Fig. 3a) . This mRNA could not be detected in T cells transduced with the GFP-RV control vector (Fig. 3b) . The amount of virally derived IFN-γ mRNA did not change upon the stimulation of the T cells, although mRNA encoding endogenous IFN-γ became readily detectable under these conditions. Despite the presence of functional mRNA no IFN-γ protein could be detected by intracellular staining in resting T cells transfected with IFN/GFP-RV (Fig. 3c) . In contrast, when such T cells were stimulated with platebound anti-CD3, strong IFN-γ production could be detected intracellularly in most of the GFP + T cells. Thus, the absence of production of recombinant IFN-γ by resting T cells is not simply a block in secretion. Rather, our results suggest a T cell specific regulation of IFN-γ production at the post-transcriptional or post-translational level.
Influence of Tc1 and Tc2 stimulating conditions on retroviral IFN-γ expression
To analyze the influence of cytokines on IFN-γ production by IFN-γ transduced CD8 + T cells, we infected CL4-TcRtransgenic T cells with IFN/GFP-RV under Tc1 or Tc2 inducing conditions. IFN-γ and IL-4-secretion of sorted GFP -CD8 + and GFP + CD8 + T cells were analyzed subsequent to the antigenic expansion of the sorted populations. Transduction of IFN-γ highly augmented TcR-induced IFN-γ secretion in Tc1, and significantly in Tc2 CL4-TcR CD8 + T cells, after 8 and 16 days of expansion, respectively (Fig. 4) . Under Tc2 conditions, IFN-γ transduction partially repressed IL-4 production in IFN/GFP-RV transduced cells (Fig. 4) . This is likely due to a feedback loop of IFN-γ acting on the IL-4 promotor via IRF-1 and IRF-2 as previously described for human CD4 + T cells [17] . Uninfected cells from the same culture (GFP -) were not affected, suggesting that a short exposure to IFN-γ present in the viral supernatant during infection does not alter IL-4 production by CD8 + Tc2 cells. As observed by others [18, 19] 
Retroviral IFN-γ transduction increases IL-12/IL-18-induced IFN-γ secretion
At least two receptor-mediated pathways can induce IFN-γ secretion in T cells. Besides a TcR-dependent pathway, an alternative antigen-independent pathway for IFN-γ secretion is implemented by the upregulation of both IL-12 and IL-18 receptor expression [20] . Triggering via the two cytokine receptors also results in IFN-γ production. We therefore analyzed IFN-γ production of transgenic CD8 + T cells transduced with GFP-RV or IFN/GFP-RV in the presence of IL-12 and IL-18. As shown in Fig. 6 , stimulation with these cytokines resulted in a strong increase in IFN-γ secretion by IFN/GFP-RV infected Tc1 cells as compared to GFP -cells from the same culture (uninfected internal control) or GFP + cells from GFP-RV infected T cells (vector control). Thus, retroviral IFN-γ expression enhanced the antigen independent IFN-γ secretion in CD8 + T cells.
Retroviral IFN-γ transduction does not alter specific cytolytic activity
An influence of IFN-γ on the homeostasis of T cells has been shown before [21] , although mature CD8 + T cells seem to be insensitive to IFN-γ due to reduced IFN-γR2 chain expression [22] . No significant difference in cytolytic activity could be discerned between GFP and IFN/GFP-RV transduced CL4 T cells. When the cytolytic activity of T cells sorted for GFP + /CD8
+ was compared at day 8 or 16
after retroviral infection, IFN/GFP-RV infected cells exhibited only a slightly higher unspecific cytolytic activity than vector controls (Fig. 7a) . Similar results were obtained Under these circumstances, IFN/GFP-RV transduced CL4 T cells exhibited improved therapeutic potency compared to GFP-RV-infected Tc1 cells (Fig. 7b) . Thus, 
Discussion
This study makes several noteworthy observations. First, we show that antigen-specific CD8 + T cells can readily be armed with IFN-γ by retroviral transduction. Interestingly, a tight regulation of IFN-γ production in CD8 + T cell was observed and only activated T cells were able to secrete the cytokine. In contrast, fibroblasts constitutively produced the cytokine upon infection with the same retroviral vector, demonstrating that regulation of IFN-γ production is intrinsic for the T cell.
Downregulation of IFN-γ was not due to the inactivation of transcription when the T cells went into quiescence, as has been observed by others [23, 24] . Virally derived mRNA encoding IFN-γ was unambiguously demonstrated in resting T cells by RT-PCR, and the amount of virally derived specific mRNA was not further enhanced upon T cell stimulation. The controversy might be due to a different retroviral constructs used in our work or to our selection of GFP expressing T cells by cell sorting. Thus, we would have selected for cells that constitutively express the LTR driven genes. In favor of this argument is that IFN-γ secretion is resumed upon T cell stimulation but virally derived mRNA is not increased. This suggests that although on/off cycling of IFN-γ production by T cells is thought to be transcriptionally regulated [25] , post-transcriptional mechanisms contribute to the control of IFN-γ production in CD8 + T cells. In agreement with our finding, it was recently shown that primed T helper cells can regulate cytokine secretion by controlling ribosomal loading of cytokine mRNA [26] . Since only the coding sequence of IFN-γ was introduced into the retroviral vector, appropriate regulatory motifs should be restricted to this region.
Virally derived IFN-γ mRNA was apparently not translated in resting IFN/GFP-RV transduced CD8 + T cells, although these cells remained GFP + . It is possible that the translation of the complete bi-cistronic mRNA might be downregulated and cells might remain GFP + due to the longevity of the GFP protein. However, it is more likely that the IRES element sufficiently uncouples the translation of both cistrons to allow independent GFP expression.
Whereas retroviral IFN-γ is downregulated in resting IFN/GFP-RV CD8 + T cells, it contributes to CD8 + T cell IFN-γ production under T-cell stimulating conditions. This is most evident in IFN/GFP-RV transduced CD8 + T cells from IFN-γ deficient mice. In IFN-γ competent CD8 + T cells, IFN/GFP-RV transduction resulted in increased T-cell receptor driven and IL-12/IL-18-induced IFN-γ secretion as compared to GFP-RV transduced T cells. Thus, the antigendependent, as well as the antigen-independent, activation pathway induces translation and/or secretion of recombinant IFN-γ in CD8 + T cells. IFN-γ plays a key role in the homeostatic control of CD8 + T cells [21] . Thus, expression of this cytokine by retroviral transduction might impair T-cell function. However, in our hands, infected Tc1 cells that over-expressed IFN-γ did not exhibit a significantly diminished viability. Growth and cytotoxic function of these T cells were also not altered throughout a 3-to 4-week restimulation period in vitro, in spite of stably increased IFN-γ levels. Thus, the control of IFN-γ secretion by physiological signals apparently permits normal T-cell functions.
It was shown that IFN-γ can directly inhibit tumor cell growth [27, 28] , enhance tumor immunogenicity by increasing tumor antigen presentation [29] , and recruit and activate innate antitumor responses [30, 31] . Furthermore, IFN-γ suppresses tumor angiogenesis by inducing angiogenesis-inhibitory chemokines [22] and, most notably, invasion of antitumor T cells into the tumor stroma seems to depend on IFN-γ signaling [9] . Comparison of IFN-γ deficient CD8 + T cells and/or Tc1 and Tc2 populations [18, 19] in different experimental tumor systems suggested that the capacity to secrete large amounts of IFN-γ is the most critical antitumor effector mechanism mediated by adoptively transferred CD8 + T cells in vivo. In the present study, we show that retrovirally armed CD8 + T cells producing increased amounts of IFN-γ delay the outgrowth of an experimental tumor when transferred into IFN-γ deficient mice. This observation suggests that CD8 + T cells can be readily equipped with IFN-γ to augment their therapeutic function. One other group has previously transduced murine tumor-specific CD8 + T lymphocytes with the IFN-γ gene [30, 31] . In these studies, a tumor-specific T-cell line that did not produce IFN-γ was transduced with a retrovirus encoding a mono-cistronic IFN-γ cDNA. One T-cell clone, obtained from the IFN-γ transduced cell line, was shown to constitutively secrete IFN-γ in vitro and displayed enhanced cytolytic activity against a tumor in vivo. In contrast, CD8 + T cells transduced with the IFN-γ gene still depended on physiological signals to secrete the cytokine in our experimental setting. This result corroborates the general observation that IFN-γ secretion and cytotoxicity are regulated independently in CD8 + T cells [32] . Thus, our study establishes compellingly that CD8 + T cells can be selectively equipped with interferon γ without the risk of immunopathology by deregulated production of this proinflammatory cytokine.
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